Loading...
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
Metastatic basal cell cancer (BCC) is an ultra-rare malignancy with no approved therapies beyond Hedgehog inhibitors. We characterized the genomics, tumor mutational burden (TMB), and anti-PD-1 therapy responses in patients with locally advanced or metastatic BCC. Overall, 2,039 diverse cancer sampl...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5790366/ https://ncbi.nlm.nih.gov/pubmed/29399405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1404217 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|